ANCHOR Biorepository, Sample Shipping and Handling
Closed Solicitation Posted
- Solicitation number
- 75N91024Q00081
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) is seeking to procure the pulling, selecting, aliquoting and shipping of up to 13,000 samples collected from participants in the NCI's ANCHOR (ANal Cancer/HSIL Outcomes Research) study, as well as the generation of a datafile. This is a commercial item acquisition processed under Simplified Acquisition Procedures, with a firm-fixed-price contract award anticipated. Quotes are due by April 30, 2024 and will be evaluated on a lowest-price technically-acceptable basis. The Government reserves the right to request revisions or clarifications from offerors.
This procurement does not have a set-aside designation. The requirement has a North American Industry Classification System (NAICS) code of 541715 - Research and Development in the Physical, Engineering, and Life Sciences. The period of performance is from May 13, 2024 to May 12, 2025, with the contractor required to have access to the ANCHOR biorepository located in Tucson, AZ and to perform the work at their own facility.
Notice text
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and lmmunoepidemiology Branch (IIB) requires pulling, selecting, aliquoting and shipping of no more than 13,000 samples collected from participants in the NCI's ANCHOR (ANal Cancer/HSIL Outcomes Research, ClinicalTrials.gov NCT02135419) and the generation of a datafile.
***PLEASE SEE ATTACHED DOCUMENTS FOR SOW/SON, TERMS AND CONDITIONS, SUBMISSION INSTRUCTIONS, AND BASIS FOR AWARD.***
This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13: Simplified Acquisition Procedures. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-03 (02/23/2024).
The requirement's North American Industry Classification System (NAICS) code is 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except. Nanotechnology and Biotechnology with a size standard of 1,000. One Firm-Fixed-Priced award is anticipated to be made as a result of this solicitation.
Files
| File | Type | Posted |
|---|---|---|
| Instructions_RFQ_75N91024Q00081.pdf | ||
| Sol_75N91024Q00081.pdf | ||
| SOW_RFQ_75N91024Q00081.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business | |
| Strong Heart Study (SHS) Renewal - Coordinating Center (CC) | National Heart Lung and Blood Institute | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Strong Heart Study (SHS) – New Cohort of Young Native American (NA) Adults | National Heart Lung and Blood Institute | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity